F3Logic’s Xeris Biopharma Holdings XERS Stock Holding History

F3Logic’s Portfolio XERS Stock Details XERS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-500	Closed	-$2.96K	–	438
2020 Q3	$2.96K	Buy	+500	New	+$2K	0.07%	175

Other funds holding XERS

Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

DAM

Deltec Asset Management New York $545M AUM 33.4% 1-Year Est. Return

F3Logic's XERS Position: Q4 2020 in Review

F3Logic sold out of Xeris Biopharma Holdings (XERS) in Q4 2020, closing a stake of 500 shares — an estimated $2.96K sold.

F3Logic first reported a position in XERS in Q3 2020 and held it in 1 quarter. The position peaked at $2.96K in Q3 2020. 96 funds tracked by Wall St. Rank hold XERS as of Q4 2020.

F3Logic reported no remaining Xeris Biopharma Holdings position as of Q4 2020 after selling out during the quarter.
F3Logic sold 500 Xeris Biopharma Holdings shares in Q4 2020, an estimated $2.96K.
F3Logic first reported a position in Xeris Biopharma Holdings in Q3 2020 and held it in 1 quarter.
F3Logic's Xeris Biopharma Holdings position peaked at $2.96K in Q3 2020.
96 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q4 2020.

Based on F3Logic's 13F filing for Q4 2020, filed 12 Feb 2021.